Image Analysis for Non-Invasive iPSC Identification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for identifying induced pluripotent stem cells (iPSCs) are invasive, destructive, or time-consuming, making it difficult to efficiently derive and assess iPSCs, especially for large quantities or therapeutic applications, as they rely on visual inspection, biochemical staining, or live cell fluorescent markers that can be damaging and impractical for high-throughput analysis.

Innovation Solution

A non-destructive and non-invasive method using image analysis to identify iPSCs by extracting image features from pixel representations, applying statistical comparison methods, and performing texture analysis with wavelet decomposition and Kullback-Leibler divergence to differentiate iPSCs from differentiated cells, allowing for real-time monitoring and high-throughput analysis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If visual inspection by trained microscopist is used to identify iPSCs, then non-invasive identification is achieved, but the process is time-consuming and cannot be scaled for large quantities of cells

Engineering Contradiction:
Improvenon-invasive identificationVSAvoididentification speed
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The patent creates a digital copy of the cell morphology through image analysis. Instead of direct human inspection of live cells, the system captures images and creates digital representations that can be analyzed automatically. This copying approach allows multiple analyses to be performed simultaneously on the same cell population, dramatically increasing productivity while maintaining the non-invasive nature of optical microscopy.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent replaces the mechanical system of human visual inspection with an automated image analysis system using computers and algorithms. The manual process of trained microscopists examining cells is substituted with automated image processing, feature extraction, and classification algorithms that can analyze thousands of cells rapidly without fatigue or subjectivity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If biochemical or immunochemical staining is used to identify iPSCs, then consistent and quantitative identification is achieved, but the method is destructive and renders samples unfit for therapeutic use

Engineering Contradiction:
Improvequantitative identificationVSAvoidcell damage
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent uses optical microscopy to create visual copies of cell morphology and applies image analysis to these copies. The system extracts quantitative features from images such as nuclear size, shape, texture, and chromatin organization. This approach provides consistent, quantitative measurement without requiring physical or chemical manipulation that would damage the cells, allowing the same cells to be used for subsequent therapeutic applications.

Inventive Principle:
Principle #26Copying

3Ease of operation

If live cell fluorescent markers are used to identify iPSCs, then non-invasive real-time monitoring is achieved, but the dyes can damage photosensitive cells and have limited application in kinetic assays due to dye loss

Engineering Contradiction:
Improvereal-time monitoringVSAvoidcell damage
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent creates digital copies of cell morphology through standard optical microscopy and performs all analysis on these images. By analyzing morphological features in images rather than using fluorescent dyes, the system achieves real-time monitoring capability without exposing cells to potentially damaging light or dye molecules. The image-based approach eliminates photosensitivity issues while maintaining the ability to monitor cells dynamically.

Inventive Principle:
Principle #26Copying

4Measurement precision

If manual visual inspection is used for quality control of large numbers of cell culture plates, then homogeneity assessment is attempted, but accurate quality control is nearly impossible to perform

Engineering Contradiction:
Improvehomogeneity assessmentVSAvoidquality control capability
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces manual visual inspection with an automated image analysis system that can objectively measure morphological homogeneity across large numbers of cell culture plates. The system uses computers to consistently extract and compare quantitative features from images, providing accurate quality control measurements that are impossible to achieve through human inspection alone.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent creates digital copies of all cell culture plates through imaging and analyzes these copies to assess homogeneity. This allows comprehensive quality control of entire plate populations rather than sampling a few plates visually. The digital copying enables batch processing and statistical analysis of homogeneity across large numbers of plates, making accurate quality control feasible.

Inventive Principle:
Principle #26Copying

Data Source

PatentEP2488992B1Mathematical image analysis based cell reprogramming with applications for epigenetic and non-epigenetic base induced pluripotent stem cell derivation
Publication Date: 2024.05.29 THE CHARLES STARK DRAPER LABORATORY INC
  • EP2488992B1 patent drawingFigure 1~3
  • EP2488992B1 patent drawingFigure 4~5
  • EP2488992B1 patent drawingFigure 6A~6D

AI summary

Mathematical and statistical image analysis methods and systems are applied to enhance and refine the process of re-programming cells, for example, to modify cells from patients into custom-matched stem cells.